Abstract:Parkinson's disease is characterized by exaggerated beta activity (13-35 Hz) in cortico-basal ganglia motor loops. Beta activity includes both periodic fluctuations (i.e. oscillatory activity) and aperiodic fluctuations reflecting spiking activity and excitation/inhibition balance (i.e. non-oscillatory activity). However, the relative contribution, dopamine dependency and clinical correlations of oscillatory vs. non-oscillatory beta activity remain unclear. We recorded, modelled and analysed subthalamic local field potentials in parkinsonian patients at rest while off or on medication. Autoregressive modelling with additive 1/f noise clarified the relationships between measures of beta activity in the time domain (i.e. amplitude and duration of beta bursts) or in the frequency domain (i.e. power and sharpness of the spectral peak) and oscillatory vs. non-oscillatory activity: burst duration and spectral sharpness are specifically sensitive to oscillatory activity, whereas burst amplitude and spectral power are ambiguously sensitive to both oscillatory and non-oscillatory activity. Our experimental data confirmed the model predictions and assumptions. We subsequently analysed the effect of levodopa, obtaining strong-to-extreme Bayesian evidence that oscillatory beta activity is reduced in patients on vs. off medication, with moderate evidence for absence of modulation of the non-oscillatory component. Finally, specifically the oscillatory component of beta activity correlated with the rate of motor progression of the disease. Methodologically, these results provide an integrative understanding of beta-based biomarkers relevant for adaptive deep brain stimulation. Biologically, they suggest that primarily the oscillatory component of subthalamic beta activity is dopamine dependent and may play a role not only in the pathophysiology but also in the progression of Parkinson's disease. KEY POINTS: Beta activity in Parkinson's disease includes both true periodic fluctuations (i.e. oscillatory activity) and aperiodic fluctuations reflecting spiking activity and synaptic balance (i.e. non-oscillatory activity). The relative contribution, dopamine dependency and clinical correlations of oscillatory vs. non-oscillatory beta activity remain unclear. Burst duration and spectral sharpness are specifically sensitive to oscillatory activity, while burst amplitude and spectral power are ambiguously sensitive to both oscillatory and non-oscillatory activity. Only the oscillatory component of subthalamic beta activity is dopamine-dependent. Stronger beta oscillatory activity correlates with faster motor progression of the disease.

L-dopa Treatment Increases Oscillatory Power in the Motor Cortex of Parkinson's Disease Patients.

Levodopa therapy affects brain functional network dynamics in Parkinson's disease

Cortico-striatal Gamma Oscillations Are Modulated by Dopamine D3 Receptors in Dyskinetic Rats

Levodopa affects functional brain networks in parkinsonian resting tremor

Effects of Different Doses of L -Dopa on Rotational Behavior and Amounts of Cells Expressing D2 Receptors in Hemiparkinsonian Rats

Force Overflow and Levodopa-Induced Dyskinesias in Parkinson's Disease.

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Dopaminergic Modulation of Local Non-oscillatory Activity and Global-Network Properties in Parkinson’s Disease: An EEG Study

Dyskinesia is Closely Associated with Synchronization of Theta Oscillatory Activity Between the Substantia Nigra Pars Reticulata and Motor Cortex in the Off L-dopa State in Rats

Resting State Cortical Oscillations of Patients with Parkinson Disease and with and Without Subthalamic Deep Brain Stimulation: a Magnetoencephalography Study.

Oscillation-specific Nodal Alterations in Early to Middle Stages Parkinson's Disease

Levodopa Reduces the Phase Lag Index of Parkinson's Disease Patients: A Magnetoencephalographic Study.

The Effect of Dopamine Replacement Therapy on Cortical Structure in Parkinson's Disease.

Eltoprazine modulated gamma oscillations on ameliorating L‐dopa‐induced dyskinesia in rats

Transient Increases in Neural Oscillations and Motor Deficits in a Mouse Model of Parkinson's Disease

Levodopa Imparts a Normalizing Effect on Default-Mode Network Connectivity in Non-Demented Parkinson’s Disease

L-Dopa induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson's disease

Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson's Disease: A Retrospective Analysis.

Oscillatory vs. non-oscillatory subthalamic beta activity in Parkinson's disease

Modulations on Cortical Oscillations by Subthalamic Deep Brain Stimulation in Patients with Parkinson Disease: A MEG Study

Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study